These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Action of pyrazolopyrimidine derivatives on American Leishmania spp. promastigotes. Avila JL; Polegre MA; Avila A; Robins RK Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 83(2):285-9. PubMed ID: 2871990 [TBL] [Abstract][Full Text] [Related]
3. Biological action of pyrazolopyrimidine derivatives against Trypanosoma cruzi. Studies in vitro and in vivo. Avila JL; Polegre MA; Robins RK Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(1):49-54. PubMed ID: 2881726 [TBL] [Abstract][Full Text] [Related]
4. Differential metabolism of allopurinol and derivatives in Trypanosoma rangeli and T. cruzi culture forms. Avila JL; Avila A; de Casanova MA Mol Biochem Parasitol; 1981 Dec; 4(5-6):265-72. PubMed ID: 6174862 [TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase. Tamta H; Kalra S; Mukhopadhyay AK Biochemistry (Mosc); 2006; 71 Suppl 1():S49-54. PubMed ID: 16487068 [TBL] [Abstract][Full Text] [Related]
6. Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosine. Bhat GA; Montero JL; Panzica RP; Wotring LL; Townsend LB J Med Chem; 1981 Oct; 24(10):1165-72. PubMed ID: 7328577 [TBL] [Abstract][Full Text] [Related]
7. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. Maher M; Kassab AE; Zaher AF; Mahmoud Z Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 5-chloroformycin A, 5-chloro-2'-deoxyformycin A and certain related 5,7-disubstituted 3-beta-D-ribofuranosylpyrazolo[4,3-d] pyrimidines from formycin A. Upadhya KG; Sanghvi YS; Robins RK; Revankar GR; Ugarkar BG Nucleic Acids Res; 1986 Feb; 14(4):1747-64. PubMed ID: 3951995 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system. Azam MA; Dharanya L; Mehta CC; Sachdeva S Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310 [TBL] [Abstract][Full Text] [Related]
10. A convenient synthesis of 6-amino-1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidin-4-one and related 4,6-disubstituted pyrazolopyrimidine nucleosides. Cottam HB; Revankar GR; Robins RK Nucleic Acids Res; 1983 Feb; 11(3):871-82. PubMed ID: 6835838 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease. Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040 [TBL] [Abstract][Full Text] [Related]
13. Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines. Krenitsky TA; Rideout JL; Koszalka GW; Inmon RB; Chao EY; Elion GB; Latter VS; Williams RB J Med Chem; 1982 Jan; 25(1):32-5. PubMed ID: 7086819 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents. El-Sayed Ali T Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688 [TBL] [Abstract][Full Text] [Related]
15. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds. Abdellatif KRA; Bakr RB Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655 [TBL] [Abstract][Full Text] [Related]
16. Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi. Jobe M; Anwuzia-Iwegbu C; Banful A; Bosier E; Iqbal M; Jones K; Lecutier SJ; Lepper K; Redmond M; Ross-Parker A; Ward E; Wernham P; Whidden EM; Tyler KM; Steverding D Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):946-50. PubMed ID: 23147154 [TBL] [Abstract][Full Text] [Related]
17. Trypanostatic drug action: its relation to relapse following chemotherapy. Ercoli N; Iudice G Chemotherapy; 1980; 26(3):218-23. PubMed ID: 7363716 [TBL] [Abstract][Full Text] [Related]
18. In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi. Botero A; Keatley S; Peacock C; Thompson RC Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):34-41. PubMed ID: 28040568 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033 [TBL] [Abstract][Full Text] [Related]
20. Pyrazolopyrimidine metabolism in African trypanosomes: metabolic similarities to Trypanosoma cruzi and Leishmania spp. Berens RL; Marr JJ; Brun R Mol Biochem Parasitol; 1980 Apr; 1(2):69-73. PubMed ID: 7003380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]